Genscript Biotech Market Cap

Genscript Biotech has a market cap or net worth of 34.7 billion as of November 20, 2025. Its market cap has increased by 34.95% in one year.

Market Cap

34.70B

Enterprise Value

31.68B

Revenue

6.50B

Ranking

n/a

PE Ratio

1.42

Stock Price

15.11

Market Cap Chart

Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 34.70B, an increase of 1,543.13%. That is a compound annual growth rate of 32.69%.

Market Cap History

Date	Market Cap	% Change
Nov 19, 2025	35.69B	69.16%
Dec 31, 2024	21.10B	-49.96%
Dec 29, 2023	42.16B	-19.78%
Dec 30, 2022	52.56B	-27.50%
Dec 31, 2021	72.50B	229.03%
Dec 31, 2020	22.03B	-33.64%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines AG	323.98B
Hansoh Pharmaceutical Group Company	236.23B
JD Health International	214.50B
Innovent Biologics	154.92B
WuXi Biologics	130.87B
Sino Biopharmaceutical	124.78B
Akeso	103.08B
Sichuan Kelun-Biotech Biopharmaceutical	101.34B

Market Cap Rankings